Related by context. All words. (Click for frequent words.) 64 MT# MEDI 64 targeted radiotherapeutic 63 cutaneous T 63 Alfacell proprietary ribonuclease 61 AAG geldanamycin analog 61 oncolytic virus therapies 61 GVAX ® 61 interventional vascular technology 61 PORxin TM platforms 60 Crofelemer budesonide foam 60 Zemiva TM 60 TELINTRA R 60 refractory chronic lymphocytic 60 including eniluracil ADH 60 PNP inhibitor 60 modified glutathione analog 60 Insegia 60 AEG# 60 Empatic ™ 60 metaglidasen 60 Onco TCS 59 accumulate preferentially 59 Wafer polifeprosan 59 histone deacetylase HDAC inhibitor 59 rxRNA 59 arsenic trioxide injection 59 Epothilone D 59 delivers fluocinolone acetonide FA 59 ELND# AZD 59 docetaxel Taxotere R 59 leading oral taxane 59 telaprevir VX 59 SinuNase ™ 59 IV Busulfex 59 Quinamed R 59 ® bortezomib 59 lexidronam injection PROSTASCINT 59 HuCNS SC ® 59 Azedra TM 59 lintuzumab SGN 59 candidate ATHX 59 Ovitrelle R Serostim 59 approved incretin mimetic 59 Solazed 59 Civacir 58 non nucleoside inhibitor 58 ZEVALIN ® 58 lexidronam injection 58 IMA# 58 ALN PCS 58 CD# CEA 58 Solazed TM 58 Expression BCE 58 sapacitabine CYC# 58 investigational oral hepatitis C 58 metastatic renal cell 58 cortisol synthesis 58 acetonide FA 58 forodesine 58 MKC# MT 58 PI3K/Akt pathway inhibitor 58 generation antisense compounds 58 Prodarsan R 58 refractory gout 58 Sudhir Agrawal D.Phil 58 include VALSTAR TM 58 pan HDAC inhibitor 58 IMiDs ® 58 R#/MEM # 58 gastrin analogue TT 58 using Crucell PER.C6 58 dasatinib Sprycel ® 58 AERx ® 58 PAION AG ISIN 58 oral Hsp# inhibitor 58 agonistic human 57 monoclonal antibody conjugated 57 novel histone deacetylase 57 Luveris R Ovidrel R 57 trastuzumab DM1 T DM1 57 stage antibody MT# 57 topical gel formulation 57 Intermezzo ® zolpidem tartrate 57 methylnaltrexone bromide 57 include Healive 57 product platforms AZX# 57 personalized cellular immunotherapy 57 development peramivir neuraminidase 57 Panzem R 57 CTAP# Capsules 57 Captisol ® 57 IMPDH inhibitor 57 novel synthetic peptide 57 candidate AQ4N 57 ALN HPN 57 davunetide intranasal AL 57 XL# anticancer compounds 57 receptor inhibiting monoclonal 57 IV APAP 57 compound ITMN 57 GRNVAC1 57 cetuximab Erbitux R 57 generation radiolabeled antibody 57 polysaccharide polymer 57 integrin inhibitor 57 Cytogen marketed 57 orally administered inhibitor 57 Pruvel TM 57 Ceflatonin R 57 HQK 57 essential thrombocythemia ET 57 TBC# 57 nucleotide analog 57 Soliris eculizumab 57 Onalta 57 tumors GIST 57 XL# XL# 57 Ozarelix 57 Budesonide foam crofelemer 57 Xcytrin R 57 Campto 57 Evoltra ® 57 candidate XP# 57 PSMA ADC 57 phase III isavuconazole 57 Visit www.nam.org 57 class anticancer quinolone 57 sulfonylhydrazine class 56 candidate bevirimat PA 56 TRIOLEX HE# APOPTONE HE# 56 TRAIL receptor antibodies 56 MCSP respectively 56 AAG KOS 56 Copegus ribavirin 56 LymphoStat B TM 56 IMiDs R 56 delivery polymer matrix 56 oral nucleoside analogue 56 thrombin component 56 molecular imaging radiopharmaceutical 56 topically applied SEPA 56 nasal calcitonin product 56 vapreotide acetate 56 GVAX R 56 Bezielle 56 sarcoma melanoma 56 hormone LHRH antagonist 56 Personalized Immunotherapy 56 using ImmunoGen TAP 56 liposomal formulation 56 Azedra 56 IAP inhibitor 56 HCV NS5B polymerase 56 HGS ETR1 mapatumumab 56 evaluating T DM1 56 trastuzumab Herceptin R 56 granulated mesalamine 56 ocular formulation 56 PDX pralatrexate 56 telomerase therapeutic 56 2 methoxyestradiol 56 Alocrest 56 include Altastaph TM 56 huN# DM1 56 Oral NKTR 56 AzaSite Plus 56 highly purified pasteurized 56 candidates bavituximab 56 treat refractory angina 56 INxin TM 56 oral prodrug 56 PRTX 56 Glassia 56 intranasal formulation 56 mertansine 56 IMiDs 56 SPL# Gel vaginal microbicide 56 novel therapeutic antibodies 56 Amigal TM 56 YONDELIS 56 MEK inhibitor 56 CYT# potent vascular disrupting 56 Archexin 55 fluorinated carbohydrate mimics 55 Gonal f R 55 Junovan TM 55 TFChem licenses 55 JVRS 55 fibrosis IPF 55 TOCOSOL Camptothecin 55 proprietary capillary aerosolization 55 irinotecan doxorubicin oxaliplatin paclitaxel 55 Cloretazine ® 55 oral proteasome inhibitor 55 gastrointestinal mucositis 55 diagnostic radiopharmaceutical 55 virus HCV protease inhibitor 55 ZFP Therapeutics 55 TRIOLEX ™ 55 Nventa proprietary CoVal 55 QUADRAMET R 55 MAGE A3 ASCI 55 5 fluorouracil leucovorin 55 diabetes irritable bowel 55 PEGylated Fab fragment 55 Azedra ™ 55 platinum chemotherapeutic 55 MSCRAMM ® 55 product candidate Lpathomab 55 isoform selective 55 KNS # 55 KSP inhibitor 55 docetaxel Taxotere ® 55 Solzira ™ 55 Shigatoxin producing E. coli 55 Curaxin CBLC# 55 therapeutic monoclonal antibody 55 targets Galectin receptors 55 Infergen R 55 vivo toxicology 55 Veronate R 55 product Zingo TM 55 EVIZON TM squalamine lactate 55 mda 7 55 candidates Azedra TM 55 generation antisense 55 5 lipoxygenase inhibitor 55 romidepsin novel 55 MVA BN R 55 pan histone deacetylase 55 Ostabolin C TM 55 non nucleoside HCV 55 Reconstruction Trauma 55 RenaZorb TM 55 Phase #b/#a clinical 55 P#X# antagonist 55 adecatumumab MT# 55 novel topoisomerase 55 FOLFOX chemotherapy 55 oral ghrelin agonist 55 Poly ICLC 55 PROSTASCINT R 55 Factor VIIa 55 commercialize ZYFLO CR 55 ApoB SNALP 55 fusion enhancers 55 PLK1 SNALP 55 pharmacogenomic translational research 54 kidney urologic 54 anti PlGF 54 Converted Organics flagship 54 AQD class 54 Pruvel ™ 54 Metastatic Melanoma 54 commercializing oxidized glutathione 54 ELACYT 54 CTA# Injection 54 manufacturing interventional vascular 54 antibody MAb 54 Kahalalide F 54 LungAlert TM 54 Phase Ib clinical trials 54 Panzem NCD 54 recombinant PSMA vaccine 54 lucinactant 54 THR beta agonist 54 nalbuphine ER 54 Zalypsis 54 cyclophosphamide chemotherapy 54 interferon gamma 1b 54 QNEXA ® 54 VEGFR2 inhibitor 54 alvespimycin 54 Filgrastim 54 CRMD# 54 orally inhaled migraine 54 Aflibercept 54 Tarmogen 54 Canvaxin TM 54 investigational humanized monoclonal antibody 54 Omacetaxine 54 PANVAC VF 54 Onalta TM 54 TRANSDUR ® 54 clinical trials lintuzumab SGN 54 mitogen activated ERK kinase 54 AKT inhibitor 54 MOVIPREP R 54 VISICOL R 54 ADAGEN 54 HCV RNA polymerase 54 INTEGRILIN R eptifibatide Injection 54 bafetinib 54 generation Hsp# inhibitor 54 apricitabine ATC 54 Unigene nasal calcitonin 54 produces potent VLP 54 rALLy clinical trial 54 busulfan 54 Initiates Enrollment 54 erlotinib Tarceva ® 54 TRISENOX R arsenic trioxide 54 clinical trials Archexin 54 include PLX IBD 54 allosteric modulator NAM 54 MGd 54 HCV protease inhibitor 54 relapsed refractory multiple myeloma 54 bevacizumab Avastin R 54 cancer indications bafetinib 54 elotuzumab 54 Traficet EN 54 gemcitabine cisplatin 54 epothilones 54 equine osteoarthritis marketed 54 Provectus Pharmaceuticals specializes 54 cosmetic cosmeceutical products 54 MKC# 54 Nipent R 54 Ostarine ™ 54 HCV protease inhibitors 54 Completes Patient Enrollment 54 HCV polymerase inhibitors 54 VQD 54 oral picoplatin 54 imatinib Gleevec ® 54 clinical trials SGN 54 anti CD3 monoclonal 53 anti botulism antibody 53 CCR9 antagonist 53 samarium Sm 53 systemic RNAi therapeutic 53 Aganocide 53 Argatroban 53 tivozanib AV 53 ViroChem 53 castrate resistant prostate cancer 53 clinical trials dacetuzumab SGN 53 XL# XL# XL# 53 XmAb ® 53 evaluating picoplatin 53 HCV nucleotide polymerase inhibitor 53 acid phosphatase PAP 53 proprietary BiTE ® 53 telomerase inhibitor drug 53 Genasense ® oblimersen 53 selective androgen receptor modulators 53 Aloprim TM allopurinol sodium 53 compound INCB# 53 visit www.genmab.com 53 candidate REP# 53 Initiate Phase 53 secretory phospholipase A2 53 MTP inhibitor 53 TELINTRA 53 alpha folate receptor 53 solid tumors ZYBRESTAT 53 AdhTAP 53 inhibitor VX 53 BioGlue ® 53 measurable tumor regressions 53 technology visit http:/www.genmab.com 53 nilotinib Tasigna ® 53 gefitinib Iressa 53 Selective Electrochemical Tumor Ablation 53 thiazolides 53 Kosan dependence 53 proprietary radiolabeled monoclonal 53 ALN TTR 53 Panzem 53 triciribine phosphate monohydrate 53 IAP inhibitors 53 OvaRex ® MAb 53 XP# XP# 53 Sulonex TM 53 TNFerade TM 53 midstage clinical 53 Vitaxin 53 mGluR5 negative 53 initiated Phase Ib 53 INOmax R 53 somatropin Kuvan R 53 recombinant subunit vaccine 53 ketolide antibiotic 53 Miraxion Amarin lead 53 topical antifungal product 53 R MSCRAMM 53 Trofex TM 53 pralatrexate injection folate analogue 53 Iluvien ® 53 hypoxia selective 53 ALTROPANE R 53 ZALBIN 53 Trofex ™ 53 investigational compounds 53 MKC# MKC# PP 53 lymphoid malignancies 53 Initiates Phase II 53 investigational hepatitis C 53 Phase IIb clinical trials 53 Bioral Amphotericin B 53 4SC AG ISIN DE# 53 About Positron Positron 53 JAK inhibitor 53 gastrointestinal disorders ATI 53 maturation inhibitor 53 ATRA IV 53 toenail onychomycosis 53 Zemiva ™ 53 anticoagulant reversing agent 53 developing ostarine selective 53 volociximab 53 IMiD 53 pharmaceuticals nutritionals 53 Silgan operates 53 intravesical infusion therapy 53 sodium Injection 53 XL# XL# XL# XL# 53 recombinant biopharmaceutical 53 Sanofi Pasteur Fluzone 53 bulk amorphous alloys 53 hepatitis B immune globulin 53 hematological tumors 53 epothilone 53 3 registrational trial 53 CYT# vascular disrupting 53 Romidepsin 53 metastatic castration resistant 53 prokinetic agent 53 TM Aganocide 53 Glioblastoma Multiforme 53 subcutaneous RELISTOR 53 INSPIRE Trial Phase III 53 VitiGam 53 PEGylated irinotecan 53 generation FBPase inhibitor 53 generation NEUGENE antisense 52 IMiDs ® compound 52 recombinant vaccines 52 entinostat 52 Cannabinor 52 recombinant protective 52 candidate CRLX# 52 Bacterin develops manufactures 52 poly ADP ribose polymerase 52 Tesetaxel 52 demonstrated antitumor activity 52 Acute Myeloid Leukemia AML 52 antigen rPA anthrax 52 OMP #R# 52 TKM PLK1 52 anionic backbone 52 ATL# [002] 52 biodefense pathogens 52 Myozyme ® alglucosidase 52 R DepoCyt 52 Genentech sanofi aventis 52 GTC recombinant human 52 albiglutide 52 gastro intestinal inflammation 52 tubulin inhibitor 52 orally bioavailable 52 sulodexide 52 lead molecular radiotherapeutic 52 vinorelbine emulsion 52 Peyronie disease Frozen Shoulder 52 EGEN 52 proprietary Capillary Aerosolization Technology 52 cell lymphoma CTCL 52 Ophena TM 52 developing Surfactant Replacement 52 AcryMed Incorporated 52 TaiGen 52 PHX# 52 ALN TTR# 52 Locked Nucleic Acid 52 TRO# 52 SYCREST 52 pentadentate logo R 52 Elan NanoCrystal 52 HSP# inhibitor 52 media transmission DMT 52 Telik logo TELINTRA 52 hyaluronidase enzyme 52 Asentar ™ 52 selective androgen receptor modulator 52 Investigational Oral 52 inflammatory autoimmune diseases 52 retaspimycin hydrochloride 52 Neupogen ® 52 FOLFOX6 chemotherapy regimen 52 INFeD R 52 advanced metastatic renal 52 seliciclib CYC# 52 GW# [003] 52 Phase 2a clinical trials 52 PRT# 52 initiate Phase 1b 52 include Alferon N 52 Naglazyme R 52 CCR5 mAb 52 FOLOTYN ® 52 MT#/MEDI-# 52 drug pipeline TAFA# 52 HuMax TAC 52 PORxin TM 52 NU# direct 52 DRAXIS Pharma 52 synthetic peptide containing 52 CYP#A# CYP#D# 52 Eligard ® 52 Telaprevir VX 52 SUVN 52 Initiates Clinical Trial 52 TNFerade ™ 52 Bilive 52 thrombopoietin TPO 52 DNA methyltransferase inhibitors 52 metastatic GIST 52 Ganciclovir 52 plasma kallikrein inhibitor 52 antisense drug 52 HepaGam B 52 enzastaurin 52 CD4 monoclonal antibody 52 potently inhibit 52 RNAi therapeutic platform 52 investigational protease inhibitor 52 virus HCV infection 52 GelSite R 52 TIMERx 52 adhesion molecule EpCAM expressing 52 SIX RO ROG 52 Pharmos pipeline 52 Evoclin R 52 Gentamicin Surgical Implant 52 midstage trials 52 DPX Survivac 52 molecular chaperone regulation 52 Hematide ™ 52 oral dihydropyrimidine dehydrogenase DPD 52 Vitrase R 52 Tarvacin Anti Cancer 52 Zybrestat 52 CDK cyclin dependent 52 OLIGON technology 52 AEGR 52 Protexia ® 52 please visit http:/www.vandapharma.com 52 Proellex TM 52 markets Testim ® 52 JOULFERON 52 polymerase inhibitor 52 molecular imaging radiopharmaceuticals 52 Enbrel rheumatoid arthritis 51 spherical metallic powders 51 ENLIGHT 51 next generation URAT1 51 RNA antagonists 51 Tronox produces 51 pan BCR ABL 51 CB2 selective receptor agonist 51 Inhalation Solution 51 Phase #/#a trial 51 evaluating tivozanib 51 Chemophase 51 transthyretin TTR 51 custom peptide synthesis 51 NYSE Amex NBY clinical 51 orally administered synthetic retinoid 51 tiapamil 51 Orthovisc R 51 research anddevelopment 51 StaphVAX R 51 Submits Response 51 receptor tyrosine kinase inhibitor 51 Receives Fast Track 51 transplantation HCT 51 dermaceutical 51 Vascular Disrupting Agent 51 MORAb 51 5 FU leucovorin 51 BCR ABL inhibitor 51 ABthrax TM raxibacumab 51 stable nucleic acid 51 developing ACAPODENE 51 Phase IIa trials 51 radezolid 51 recombinant FVIII 51 Cerashield ™ 51 world safest multivalent 51 Hepavax Gene ® 51 Exherin TM 51 HYVISC ® treatment 51 metabolic disorders Saizen R 51 NS5b 51 Arno Therapeutics 51 TRANSDUR ™ 51 Avid Bioservices 51 histone deacetylase inhibitor 51 XOMA 3AB 51 drug conjugate 51 HER2 positive metastatic breast 51 omecamtiv mecarbil formerly 51 HGS# 51 Inotek Pharmaceuticals Corporation 51 EHT AGN 51 compound perifosine 51 XAGRID 51 Refractories segment 51 initiate multicenter 51 investigational hepatitis B 51 cathepsin K inhibitor 51 ThermoDox ® clinical 51 Lexiscan R 51 Preotact R 51 GRN#L 51 Restanza TM 51 STRIANT ® 51 apoptosis inducer 51 VentiRx Pharmaceuticals 51 Genasense oblimersen sodium Injection 51 Chugai Pharma USA 51 trodusquemine MSI 51 protein tyrosine phosphatase 1B 51 OMNARIS HFA 51 THALOMID 51 MET inhibitor 51 Ethyol 51 Genasense R oblimersen 51 Aganocide ® 51 memantine HCl 51 markets COLAZAL 51 forodesine hydrochloride 51 HEPLISAV ™ 51 recombinant polyclonal antibodies 51 Betaseron ® 51 nucleotide polymerase inhibitor 51 Lenocta 51 Cariprazine 51 Library HuCAL 51 hepatitis C viral infection 51 Sylvie Gregoire President 51 Menjugate 51 TKB# 51 transcriptase inhibitor NNRTI 51 SUMAVEL 51 novel peptide 51 compound CMX# 51 See BioWorld Today 51 ostarine 51 μg dose 51 targeting CD# 51 Biopharmaceuticals AG 51 TKM ApoB 51 PGL# 51 Allovectin 7 r 51 Asentar TM 51 Tezampanel 51 Survivin antagonist 51 CRLX# 51 NovaBay Aganocide 51 Aurexis 51 Alferon N Injection 51 lorvotuzumab mertansine 51 imetelstat GRN#L 51 Alferon LDO 51 DepoCyt 51 ospemifene 51 PEGylated interferon 51 personalized dendritic cell 51 Insteel operates 51 Submits NDA 51 peripheral neuropathy aggravated 51 Taisho Pharmaceuticals 51 SparVax ™ 51 Xcellerex FlexFactory 51 MAXY VII 51 epoetin zeta 51 LUCENTIS r 51 ELADUR ™ 51 including thyroiditis RA 51 catalytic antioxidant compounds 51 anticancer compound 50 Androxal TM 50 UVIDEM 50 GetGoal Phase III 50 Anthim 50 NovaDel oral spray 50 neratinib 50 Hsp# Inhibitor 50 aneurysms AAA 50 MVA HPV IL2 50 Triapine 50 Tekmira SNALP stable 50 phase IIb study 50 sunitinib Sutent ® 50 Cx# [002] 50 Hematide TM 50 VANTAS ® 50 preclinical compounds 50 FluBlok 50 TP# CETi 1 50 Tyzeka Sebivo 50 Like Particle VLP 50 taxane resistant 50 bone marrow aspirates 50 Reports Preclinical Data 50 vinca alkaloid 50 smallpox vaccine IMVAMUNE R 50 rThrombin 50 commercialize CorMedix drug 50 Presents Preclinical 50 Fx #A 50 Nanobody 50 HGS ETR2 50 HP Acthar R 50 irreversible inhibitor 50 pharmaceuticals biologics 50 PDE4 inhibitor 50 AN# novel 50 CholeraGarde R 50 OraTest R 50 Predictive medicine 50 proprietary VLP 50 Exherin 50 custom oligonucleotides 50 M2 subunit 50 Zolpimist ™ 50 therapeutic peptide 50 Company AMEX SNT 50 Entereg R 50 AQ4N 50 Oasmia 50 resorbable biomaterials 50 Nanobody R 50 #L Sterilizer 50 ABL inhibitor 50 DosePro TM 50 inhibit oxidative stress 50 dacetuzumab SGN 50 Oracea TM 50 buccal soluble film 50 ENMD # 50 Biomoda www.biomoda.com 50 investigational HCV polymerase 50 Hubbell Incorporated operates 50 CoFactor 50 delta opioid receptor 50 active AKT inhibitor 50 Idiopathic pulmonary fibrosis 50 SNALP technology 50 Xyntha 50 Zenvia ™ 50 CNS Disorders 50 reversible inhibitor 50 HIV integrase inhibitors 50 BUPHENYL R 50 Adenosine Therapeutics 50 Pharmos proprietary 50 RNAi therapeutic targeting 50 Amlodipine Besylate Tablets 50 Aganocide R 50 EV# vaccine 50 dimebon latrepirdine 50 Truvada emtricitabine 50 mg TID 50 Qnexa TM 50 Quinamed 50 Nasdaq PARD 50 cGMP manufacture 50 skeletal sarcomere activators 50 eSVS MESH 50 MVA BN ® 50 Company Nasdaq RGDX 50 GRN# 50 Vicriviroc 50 multi kinase inhibitor 50 plasmid DNA pDNA 50 Hexvix ® 50 Phase III Pivotal 50 IL# PE#QQR 50 HCD# [002] 50 GLPG# 50 phase IIb clinical 50 mg RDEA# 50 Nicotine Conjugate Vaccine 50 Synagis palivizumab 50 granted Ortec 50 Elotuzumab 50 liver resection surgeries 50 Triapine R 50 GlaxoSmithKline Biologicals GSK Biologicals 50 systemically administered 50 urocortin 2 50 NeoVisc R 50 Acetavance TM 50 lung esophageal 50 HuMax EGFr 50 CholeraGarde R Peru 50 including nutritionals devices 50 GSK# [002] 50 NeutroSpec TM 50 immunotoxin 50 sublingual tablets 50 Polymerase Inhibitor 50 R vancomycin hydrochloride 50 evaluating satraplatin 50 WiLAN founded 50 SNS# T 50 zolpidem tartrate sublingual tablet 50 GTC recombinant form 50 Erimos 50 Fortigel 50 Taligen Therapeutics 50 CINtec R 50 systemic lupus erythematosus lupus 50 multicenter Phase III 50 gallium containing 50 deforolimus 50 Inc. www.micromet inc.com 50 commercial bioproduction 50 Hepatitis C Virus HCV 50 PKC# 50 compound PMX # 50 AVONEX ® 50 Phase 2b Clinical Trial 50 Cerashield TM 50 NTDDS 50 PNT# 50 CCX# 50 recombinant hepatitis B 49 TheraSphere R 49 RECOTHROM ® 49 Pimavanserin 49 Trofex 49 drug conjugate ADC 49 HepaGam B R 49 Pharma Merck Serono 49 MUSE ® 49 cellular baseband 2G 49 Nasdaq PGNX today 49 budesonide MMX ® 49 oral ferric iron 49 CLORETAZINE TM VNP#M 49 transfection reagents 49 HEPLISAV TM hepatitis B 49 investigational pan BCR 49 Therapeutic Competitors Companies 49 Valortim TM 49 recombinant Factor VIIa 49 novel L DOS# 49 Oncaspar 49 FACTIVE R gemifloxacin 49 mapatumumab 49 mesylate tablets approved 49 Nitoman 49 Shigamabs R 49 preclinical efficacy 49 Genome Therapeutics 49 IMPACS R 49 Inc. NASDAQ TRGT 49 Sezary syndrome 49 developing Zerenex TM 49 Diep Tran MD 49 KL4 Surfactant 49 human IgG1 monoclonal 49 IPL# 49 TRACON Pharmaceuticals 49 Locteron ® 49 PEGylated 49 Gammagard Liquid 49 pharmacological chaperone 49 Cyclooxygenase Inhibiting Nitric Oxide 49 multicenter Phase II 49 Presents Preclinical Data 49 REGN# 49 LE SN# 49 transthyretin TTR mediated amyloidosis 49 ReFacto 49 HIV integrase inhibitor 49 ASG 5ME 49 Phase IIb trials 49 Diamyd ® 49 Chronic myeloid leukemia CML 49 Skin Cholesterol Test 49 Guanilib 49 AVEO Pharmaceuticals NASDAQ 49 INCB# [001] 49 adrenergic regulation 49 vaccine GRNVAC1 49 treat lupus renal 49 Somatuline Depot 49 PRESEPT study 49 Vertex retains 49 huC# DM4 49 neuroendocrine carcinoma 49 Marqibo TM 49 Locteron exclusively 49 CytoGam 49 CORTOSS R 49 gamma secretase inhibitor 49 therapeutic monoclonal antibodies 49 pomalidomide 49 biotherapeutic drugs 49 Wellbutrin XL ® 49 pharmaceuticals biopharmaceuticals 49 generation URAT1 inhibitor 49 LentiVector technology 49 MEK Inhibitor 49 JAK1 49 generation rPA anthrax 49 mg q#h 49 Ceragenin ™ 49 Xanthus Pharmaceuticals Inc. 49 hyperphenylalaninemia HPA due 49 Enhanze 49 ANAVEX #-# [002] 49 perifosine KRX 49 CyDex Pharmaceuticals 49 PEG PAL 49 SEQureDx TM 49 pulmonary alveolar 49 patented DepoVax TM 49 COU AA 49 BioMarin Genzyme LLC 49 Thalomid ® 49 novel antiviral therapeutics 49 HCV polymerase 49 HGS ETR1 49 Rigel R# 49 recombinant insulin 49 BioGlue R 49 dextromethorphan quinidine 49 Through Glycoscience R 49 trivalent influenza vaccine 49 please visit http:/www.atherogenics.com 49 Restoraderm R 49 Initiates Clinical 49 Begins Dosing 49 CEQ# 49 ARRY # 49 signal detection CTSD 49 vivo preclinical 49 Vitaflo Scandinavia AB 49 Phase 1b clinical trials 49 Altastaph 49 Dynepo TM 49 clinical trials Archexin ® 49 Oncobionic 49 Urokinase 49 Fc fusion protein 49 commercializing ophthalmic 49 proprietary PEGylation 49 humanised antibody 48 Fortical ® 48 Pentad TM 48 lead Aganocide compound 48 Glioblastoma multiforme GBM 48 Nascobal ® 48 Elusys 48 Loramyc TM 48 Genedata Expressionist ® 48 DiLA2 48 pneumococcal conjugated vaccine 48 chemistry pharmacology toxicology 48 axitinib 48 investigational smallpox vaccine 48 INS# [001] 48 RNAi Therapeutic 48 Staphylococcus aureus Polysaccharide Conjugate 48 Hib conjugate vaccine 48 BioGlue Surgical Adhesive 48 Actilon 48 Replagal TM 48 CORT # 48 selective kinase inhibitor 48 Urocidin TM 48 5 HT6 antagonist 48 developing Zerenex ferric 48 colorectal liver 48 patented BEMA 48 GlaxoSmithKline Biologicals GSK 48 administered intranasally 48 gastric pancreatic 48 TSO3 STERIZONE R 48 Loramyc ™ 48 pancreatic neuroendocrine 48 Zenvia TM 48 technologies patented bioengineered 48 NEUMUNE 48 DELATESTRYL 48 Avian Transgenic Technology 48 Nasdaq CRXL 48 BiTE antibodies targeting 48 Alvesco R 48 Lisofylline LSF 48 Protexia R 48 INTERNATIONAL HOLDINGS INC.